Semuloparin for Preventing an occurrence of prolonged Morbidity mortality and / or in a patient who has suffered Hip Fracture Surgery

摘要

It refers to the use of semuloparina or pharmaceutically acceptable salts for long-term prevention of death and / or morbidity, more specifically, venous thrombosis and mortality, In a patient who had undergone hip fracture surgery, 1: an ultra-low molecular weight liver with an average molecular weight of 2000 to 3000 daltons, an XA reaction of 145 to 180 mg, and an IIA reaction of less than 5 U / mg, For long-term prevention of death and / or morbidity in a patient who has had hip surgery,The event was selected from fatalistic and dead hemoglobin and its effectiveness was clinically tested in a phase III clinical trial.